Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Thrombin for Topical Use in Hepatic Resection Bleeding
CTR20190894Phase 3Terminated
- Sponsor
- Suzhou Zelgen Biopharmaceuticals
- Start
- May 2019
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of thrombin alfa in Not applicable, sponsored by Suzhou Zelgen Biopharmaceuticals. Started May 2019; status: terminated.
02
Drugs
thrombin alfa
03
Conditions
Not applicable
Beyond the preview
Go deeper on CTR20190894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190894.